What's breaking now, across thousands of outlets.
The drugmaker Alkermes said a therapy called an orexin agonist for the first time showed potential to treat people with ADHD in an early-stage study.
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
Fresh from its rebrand last week, Novo CEO Maziar Mike Doustdar spelled out on Monday the strategic vision that goes along with it. At the Danish drugmaker capital markets day in London ...
Luft anhalten, Kopfstand turnen, sich erschrecken lassen: Es gibt einiges, das Schluckauf in die Flucht schlagen soll. Experten erklären, wie das Hicksen entsteht, und was alle Tipps gemeinsam haben.
As captain for your club and the national side, you are expected to lead by example. But that’s not what transpired with Switzerland and Sunderland skipper Granit Xhaka, who admitted on Monday that he…
When people stop taking antidepressants, they can feel terrible—their mood can plummet and anxiety can spike. But are these symptoms caused by withdrawal, or are they signs of a relapse?
Intelliguard’s new interactive ROI tool helps U.S. and Canadian health systems quantify potential five-year savings across medication inventory, labor, waste, charge capture and supply-chain…
New global survey finds 71% of employees connect their reason for seeking care to workplace stress; half say better management would have resolved it. 60% say we’re overly reliant on therapy.
